With NIH Funding, Freedman Lab to Use Kidney Organoids to Predict Adverse Effects of Genome Editing
October 1, 2019 | Categories: Announcements, Award, Research |Nearly 40 million Americans are impacted by chronic kidney disease, a family of progressive conditions associated with widespread health complications, including higher risk for heart disease. Read More
With CRISPR, Modeling Disease in Mini Organs
May 6, 2016 | Categories: Research |Traditionally, gene therapy efforts have attempted to treat genetic diseases by modifying DNA inside a patient’s body, but it has been a challenge to deliver the genetic material to all the target tissue, let alone to do so safely. But in recent years, advances in gene editing and stem cell research have enabled scientists to […] Read More